FDA Adverse Event Injury Summary report: N

EVERFLEX SELF-EXPANDING PERIPHERAL STENT STANDARD

MDR report key: 7298559 · Received February 26, 2018

Report

Report Number
2183870-2018-00114
Event Type
Injury
Date Received
February 26, 2018
Date of Event
July 8, 2013
Report Date
February 28, 2018
Manufacturer
COVIDIEN
Product Code
NIP
PMA / PMN Number
P110023
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

CORRECTED INFORMATION: 6X40 EVERFLEX SELF-EXPANDING STENT WAS USED (ALONG WITH 2 IN.PACT ADMIRAL DRUG-ELUTING BALLOONS) DURING THE INDEX PROCEDURE. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

THE INDEX PROCEDURE WAS PROMPTED ON (B)(6) 2013 BY A PERSISTENT RESIDUAL STENOSIS IN THE RIGHT MID AND DISTAL SFA. DURING THE INDEX PROCEDURE, TWO IN.PACT ADMIRAL DRUG-ELUTING BALLOONS AND ONE 6X40 EVERFLEX PTA BALLOON WERE USED SUCCESSFULLY. IT WAS REPORTED THAT APPROXIMATELY 4 MONTHS POST INDEX PROCEDURE, THE PATIENT COMPLAINED OF SLIGHT TINGLING IN BOTH LEGS (NOV 2013), NO TREATMENT WAS GIVEN. APPROXIMATELY 31 MONTHS POST PROCEDURE, THE PATIENT SUFFERED A RESTENOSIS OF THE RIGHT DISTAL SFA ((B)(6) 2016). AFTER DIAGNOSTIC PROCEDURE, THE PATIENT WAS TREATED WITH LITHOPLASTY, DATE OF RESOLUTION ((B)(6) 2018).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
141221 EVERFLEX SELF-EXPANDING PERIPHERAL STENT STANDARD STENT, SUPERFICIAL FEMORAL ARTERY NIP COVIDIEN

Patients

Seq Age Sex Outcome Treatment
1 69 YR Required Intervention